In CRC, miR-193a-3p showed tumor suppressor properties by arresting the cell cycle and inducing apoptosis; in contrast, ERBB4 enhanced the survival rate of CRC cells with activated P13K, EGFR pathway, and inflammation factors [130,131]. This evidence concerns the gene ERBB4 and colorectal carcinoma.